Abstract

Fetoscopic laser ablation surgery (FLS), a new treatment for vasa previa (VP), allows for full term vaginal delivery in some patients, but its upfront costs may be a barrier to more widespread use. We aimed to compare costs and outcomes of two strategies for third trimester management of Type II VP: (1) FLS referral and (2) standard management (SM).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call